Antidiabetic, antioxidant and antihyperlipidemic status of Heliotropium zeylanicum extract on streptozotocin-induced diabetes in rats

Biol Pharm Bull. 2006 Nov;29(11):2202-5. doi: 10.1248/bpb.29.2202.

Abstract

The potential role of the methanolic extract of Heliotropium zeylanicum (BURM.F) LAMK (MEHZ) in the treatment of diabetes along with its antioxidant and antihyperlipidemic effects was studied in streptozotocin-induced diabetic rats. Oral administration of (MEHZ) 150 and 300 mg/kg/d for 14 d significantly decreased the blood glucose level and considerably increased the body weight, food intake, and liquid intake of diabetic-induced rats. MEHZ significantly decreased thiobarbituric acid reactive substances and significantly increased reduced glutathione, superoxide dismutase and catalase in streptozotocin-induced diabetic rats at the end of 14 d of treatment. The study also investigated the antihyperlipidemic potential of MEHZ. The results show that the active fraction of MEHZ is promising for development of a standardized phytomedicine for the treatment of diabetes mellitus.

MeSH terms

  • Administration, Oral
  • Animals
  • Antioxidants / administration & dosage
  • Antioxidants / isolation & purification
  • Antioxidants / therapeutic use*
  • Blood Glucose / analysis
  • Body Weight / drug effects
  • Catalase / metabolism
  • Diabetes Mellitus, Experimental / chemically induced
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Experimental / prevention & control*
  • Drinking / drug effects
  • Eating / drug effects
  • Glutathione / metabolism
  • Heliotropium / chemistry*
  • Hypercholesterolemia / chemically induced
  • Hypercholesterolemia / metabolism
  • Hypercholesterolemia / prevention & control
  • Hypertriglyceridemia / chemically induced
  • Hypertriglyceridemia / metabolism
  • Hypertriglyceridemia / prevention & control
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / isolation & purification
  • Hypoglycemic Agents / therapeutic use*
  • Hypolipidemic Agents / administration & dosage
  • Hypolipidemic Agents / isolation & purification
  • Hypolipidemic Agents / therapeutic use*
  • Liver / drug effects
  • Liver / metabolism
  • Male
  • Phytotherapy / methods
  • Plant Extracts / administration & dosage
  • Plant Extracts / chemistry
  • Plant Extracts / therapeutic use*
  • Rats
  • Rats, Wistar
  • Streptozocin
  • Superoxide Dismutase / metabolism
  • Thiobarbituric Acid Reactive Substances / metabolism
  • Tolbutamide / pharmacology

Substances

  • Antioxidants
  • Blood Glucose
  • Hypoglycemic Agents
  • Hypolipidemic Agents
  • Plant Extracts
  • Thiobarbituric Acid Reactive Substances
  • Streptozocin
  • Tolbutamide
  • Catalase
  • Superoxide Dismutase
  • Glutathione